Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SSc”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02426229
What this trial is testing

Safety & Suitability of Dabigatran to Inhibit Thrombin in Scleroderma

Who this might be right for
SclerodermaInterstitial Lung Disease
Medical University of South Carolina 15
Not applicableStudy completedNCT04614441
What this trial is testing

NICEFIT-ON: A Study Under Routine Clinical Practice in Taiwan to Observe the Long-term Outcome of People With Certain Types of Lung Disease (PF-ILD, SSc-ILD, IPF) Who Start Treatment With Nintedanib

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 214
Large-scale testing (Phase 3)Looking for participantsNCT06716606
What this trial is testing

Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)

Who this might be right for
Connective Tissue Diseases
GlaxoSmithKline 514
Early research (Phase 1)Looking for participantsNCT07115745
What this trial is testing

Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases

Who this might be right for
Refractory Autoimmune Diseases
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company 125
Not applicableActive Not RecruitingNCT07661836
What this trial is testing

Personalized Online Occupational Therapy Intervention for Adults With Scleroderma

Who this might be right for
SclerodermaScleroderma (Limited and Diffuse)Systemic Sclerosis (SSc)
Universidad de Zaragoza 24
Testing effectiveness (Phase 2)Ended earlyNCT04915950
What this trial is testing

Assess the Effect of Oral Temanogrel on Digital Blood Flow in Adult Participants With Raynaud's Phenomenon Secondary to Systemic Sclerosis

Who this might be right for
Raynaud's Phenomenon Secondary to Systemic Sclerosis
Pfizer 13
Large-scale testing (Phase 3)Not Yet RecruitingNCT07759557
What this trial is testing

Efficacy of A Non-Invasive Botulinum Toxin Microneedle Pad for the Treatment of Secondary Raynaud's Phenomenon

Who this might be right for
Systemic Sclerosis (SSc)Raynaud Disease Secondary to Scleroderma
Khon Kaen University 72
Early research (Phase 1)Looking for participantsNCT06822881
What this trial is testing

CT1190B in the Treatment of Patients With Moderate to Severe Refractory Systemic Lupus Erythematosus (SLE) or Refractory/Progressive Systemic Sclerosis (SSc)

Who this might be right for
Systemic Lupus Erythematosus (SLE)Systemic Sclerosis (SSc)
Beijing GoBroad Hospital 27
Testing effectiveness (Phase 2)Looking for participantsNCT07641634
What this trial is testing

PRO-203 in Healthy Volunteers and Participants With Systemic Sclerosis.

Who this might be right for
Healthy VolunteersSystemic Sclerosis (SSc)Scleroderma, Systemic+1 more
Prolium Bioscience, Inc 44
Not applicableStudy completedNCT07465211
What this trial is testing

Comparative Evaluation of Clinical Success of BIOFLX Crowns and SSC in Primary Molars

Who this might be right for
Dental CariesRestored Decayed Teeth and Post-operative Sensitivity
satish vishwanathaiah 36
Not applicableNot Yet RecruitingNCT06769399
What this trial is testing

Relationship Between Pelvic Floor Dysfunctions and Sexual Dysfunction in Female Patients with Systemic Sclerosis

Who this might be right for
Systemic Sclerosis (SSc)Sexual DysfunctionsPelvic Floor Disorder
Istanbul University - Cerrahpasa 140
Very early researchNot Yet RecruitingNCT06982534
What this trial is testing

Clinical Study on the Treatment of Systemic Sclerosis With UTAA91 Injection.

Who this might be right for
Systemic Sclerosis (SSc)
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 24
Large-scale testing (Phase 3)Study completedNCT02629393
What this trial is testing

Study of ORGN001 (Formerly ALXN1101) in Neonates, Infants and Children With Molybdenum Cofactor Deficiency (MOCD) Type A

Who this might be right for
Molybdenum Cofactor Deficiency, Type A
Origin Biosciences 5
Not applicableLooking for participantsNCT06894654
What this trial is testing

DERMATOMICS: Identifying Regulators of Skin Homeostasis

Who this might be right for
Systemic Sclerosis (SSc)
Relation Therapeutics 500
Not applicableUnknownNCT00901797
What this trial is testing

Arthroscopic Rotator Interval Closure in Shoulder Instability Repair

Who this might be right for
Recurrent Shoulder Dislocations
Tel-Aviv Sourasky Medical Center 100
Not applicableStudy completedNCT02837549
What this trial is testing

Novel Rehabilitation Strategies to Improve Arm Function in Patients With Scleroderma

Who this might be right for
SclerodermaSsc
University of Michigan 21
Very early researchLooking for participantsNCT06888960
What this trial is testing

Safety Study of CC312 in Autoimmune Disease Patients

Who this might be right for
Systemic Lupus Erythematosus (SLE)Idiopathic Inflammatory Myopathy (IIM)Systemic Sclerosis (SSc)+3 more
CytoCares Inc 18
Early research (Phase 1)Not Yet RecruitingNCT07523282
What this trial is testing

Safety and Preliminary Efficacy of HN2302 in Patients With Autoimmune Diseases

Who this might be right for
Autoimmune DiseaseSystemic Lupus ErythematosusSystemic Sclerosis (SSc)
Shenzhen MagicRNA Biotechnology Co., Ltd 12
Not applicableStudy completedNCT07402863
What this trial is testing

Self-Guided Resilience-Building Energy Management to Enhance Well-being (RENEW) Intervention for People With Systemic Sclerosis (SSc)

Who this might be right for
Systemic Sclerosis
University of Michigan 43
Testing effectiveness (Phase 2)Study completedNCT02228850
What this trial is testing

Study of Acute Peripheral Vascular Effects, Safety and Tolerability in Subjects With Raynaud's Phenomenon Secondary to Systemic Sclerosis

Who this might be right for
Raynaud's Phenomenon Secondary to Systemic Sclerosis
NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.) 35
Next Page